Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Seth Tasker | M | 45 | 16 years | |
Norman Selby | M | 71 | 12 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Steven Holtzman | M | 70 |
Warp Drive Bio, Inc.
Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Warp Drive Bio, Inc. focused on proprietary genomic technology to discover drugs of natural origin. The firm deployed proprietary platforms Genome Mining and Small Molecule Assisted Receptor Targeting (SMART) to discover and develop novel molecules addressing new pharmacologic mechanisms. The company was founded by Gregory L. Verdine, George McDonald Church, and James A. Wells in 2012 and was headquartered in Cambridge, MA. | 22 years |
Laurence Reid | M | 60 |
Warp Drive Bio, Inc.
Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Warp Drive Bio, Inc. focused on proprietary genomic technology to discover drugs of natural origin. The firm deployed proprietary platforms Genome Mining and Small Molecule Assisted Receptor Targeting (SMART) to discover and develop novel molecules addressing new pharmacologic mechanisms. The company was founded by Gregory L. Verdine, George McDonald Church, and James A. Wells in 2012 and was headquartered in Cambridge, MA. | 7 years |
Lawrence Bloch | M | 58 | 11 years | |
Gerald Quirk | M | 56 | 6 years | |
Gregory Verdine | M | 65 |
Warp Drive Bio, Inc.
Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Warp Drive Bio, Inc. focused on proprietary genomic technology to discover drugs of natural origin. The firm deployed proprietary platforms Genome Mining and Small Molecule Assisted Receptor Targeting (SMART) to discover and develop novel molecules addressing new pharmacologic mechanisms. The company was founded by Gregory L. Verdine, George McDonald Church, and James A. Wells in 2012 and was headquartered in Cambridge, MA. | 4 years |
Thomas Lynch | M | 63 | 5 years | |
Gwen A. Fyfe | M | 72 | 4 years | |
William Carson | M | 65 | 2 years | |
John Lee | M | 56 | 5 years | |
Martin Babler | M | 59 | 6 years | |
Elisabeth Leiderman | M | 47 | 2 years | |
Patrick Lee | M | 67 | 7 years | |
Neil Exter | M | 65 | 5 years | |
Paula Cobb | F | 51 | 3 years | |
Jaren Madden | F | - | 7 years | |
Dave Grayzel | M | 56 | 8 years | |
Peter Thompson | M | 64 | 3 years | |
George Scangos | M | 76 | - | |
Franklin H. Moss | M | 75 | 10 years | |
Christopher M. Lindblom | M | 52 | 7 years | |
Christine Poon | F | 71 | 2 years | |
Matthew Foy | M | - | - | |
Cynthia Hu | M | 54 | 2 years | |
Ian Smith | M | 58 | 11 years | |
Deborah Miller | M | 48 | 7 years | |
Sharon Townson | M | 49 |
Warp Drive Bio, Inc.
Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Warp Drive Bio, Inc. focused on proprietary genomic technology to discover drugs of natural origin. The firm deployed proprietary platforms Genome Mining and Small Molecule Assisted Receptor Targeting (SMART) to discover and develop novel molecules addressing new pharmacologic mechanisms. The company was founded by Gregory L. Verdine, George McDonald Church, and James A. Wells in 2012 and was headquartered in Cambridge, MA. | 5 years |
Dorota McKay | F | 42 | - | |
Patrick F. Kelly | M | 60 | 3 years | |
Jeffery L. Kutok | M | 57 | 10 years | |
Anna Trask | F | 67 | 5 years | |
Michael Ferraresso | M | - | 4 years | |
Anthony Philippakis | M | 48 | 3 years | |
Michael Landsittel | M | 52 | - | |
David Roth | M | 61 | 2 years | |
Paul Melone | M | - | 15 years | |
Elaine Cope | F | - | 6 years | |
Roger H. Brown | M | 67 | - | |
Colleen Wilson | F | 47 | 2 years | |
Elizabeth G. Trehu | M | 64 | 2 years | |
Tamyra A. Toole | F | - | 9 years | |
Winselow Tucker | M | 56 | - | |
James Nichols | M | - |
Warp Drive Bio, Inc.
Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Warp Drive Bio, Inc. focused on proprietary genomic technology to discover drugs of natural origin. The firm deployed proprietary platforms Genome Mining and Small Molecule Assisted Receptor Targeting (SMART) to discover and develop novel molecules addressing new pharmacologic mechanisms. The company was founded by Gregory L. Verdine, George McDonald Church, and James A. Wells in 2012 and was headquartered in Cambridge, MA. | - |
Steven Kafka | M | 54 | 3 years | |
James Tananbaum | M | 60 | 6 years | |
Joshua D. Hamermesh | M | 51 | 3 years | |
Rachel King | F | 64 |
Warp Drive Bio, Inc.
Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Warp Drive Bio, Inc. focused on proprietary genomic technology to discover drugs of natural origin. The firm deployed proprietary platforms Genome Mining and Small Molecule Assisted Receptor Targeting (SMART) to discover and develop novel molecules addressing new pharmacologic mechanisms. The company was founded by Gregory L. Verdine, George McDonald Church, and James A. Wells in 2012 and was headquartered in Cambridge, MA. | - |
Herm Rosenman | M | 76 | 4 years | |
Harry Hixson | M | 84 | 9 years | |
Pedro D. Santabarbara | M | 71 | 4 years | |
D. Ronald Daniel | M | 94 | 2 years | |
Arnold Levine | M | 84 | 6 years | |
Troyen Brennan | M | 69 | - | |
Geoff Horwitz | M | - | 6 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 55 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ronald Vigliotta
- Personal Network